Skip to content
Oxcia
Menu
Close
About us
Open menu
About us
Management
Board
Scientific Advisory Board
Collaborators
Partnerships
History
Careers
Scientific Platform
Open menu
Scientific Platform
Glossary
Pipeline
Open menu
Pipeline
OXC-101
OXC-201
Investors
Open menu
Investors
Governance
Ownership structure
Financial reports
Presentations
Upcoming events
Investor contact
Investerare
Open menu
Investerare
Bolagsstyrning
Bolagsstämma
Ägarstruktur
Finansiella rapporter
Pressmeddelanden
Presentationer
Kalender
Investerarkontakt
News and Press
Contact
Search
Home
›
New tablet formulation of karonudib is introduced in the clinical trials
New tablet formulation of karonudib is introduced in the clinical trials
November 18, 2020
Latest news
Oxcia AB publicerar Bokslutskommuniké för 2024
February 21, 2025
Oxcia AB Publishes Year-End Report for 2024
February 21, 2025
OXC-101 has been granted ODD status by the FDA in AML
February 20, 2025
Read more news
Search
More results
Generic filters
Search!
